29.09.09 Following the decision of the US FDA, the European Medicines Agency (EMEA) committee CHMP has recommended two adjuvanted vaccines against pandemic H1N1, Novartis' Focetria and GlaxoSmithKlines Pandemrix, for approval. The green...
more
20.09.09 Brussels – Research on adverse drug effects is the focus of a new funding call published by the European Commission in August. Biotech SMEs can participate in the three-year projects funded by a3m in six areas: the long-term...
more
06.09.09 Brusssels – Genzyme Corp (Cambridge, US) has been given the green light by the European Commission for EU-wide marketing of Mozobil® + granulocyte-colony stimulating factor (G-CSF), a treatment for certain groups of blood cancer...
more
09.06.09 Utrecht- PanGenetics B.V. will start the first-in-man clinical trials for its Nerve Growth Factor (NGF) inhibiting antibody PG110 as a break-through treatment for chronic pain. PG110 is a humanised antibody that binds to NGF with...
more
29.04.09 Dr Christian Schneider from the Paul Ehrlich Institute, Germany’s drug authority, will chair the newly founded Committee for Advanced Therapies (CAT), which is to assess the quality, safety and efficacy of advanced therapy...
more
